Skip to main content
Cancer Explained
Beginner 3 min readEditorial review complete

Zelboraf (Vemurafenib): What It Is and What to Expect

Zelboraf (Vemurafenib) is a targeted therapy called a kinase inhibitor used to help treat melanoma with a BRAF V600 gene change and a rare blood disorder. A plain-language guide to what it is, how it is given, and its common side effects. Based on the National Cancer Institute.

AI-assisted and source verified. Not reviewed by a healthcare professional unless specifically stated.

Sources last checked: 2026-07-14Last updated: 2026-07-14Next planned review: 2027-07-14

How this page was created

Cancer Explained uses AI to organize and translate information from the authoritative sources cited on each page. Automated checks review claims, citations, clarity, duplication, and potential safety concerns before publication. Our content is not currently reviewed by physicians unless a specific qualified reviewer is named on the page. Cancer Explained provides general education and should not replace advice from your healthcare team.

Editorial status — Editorial review complete. This page completed Cancer Explained's editorial checks (sources, safety, plain language, duplication). It has not been reviewed by a physician or other healthcare professional.

General education — varies by person. Answers genuinely differ between people. This page explains what commonly varies and points you to your care team for your situation.

Human medical review: not completed. At this time, most Cancer Explained content has not been reviewed by a physician or other healthcare professional. Pages with documented human medical review identify the reviewer, credentials, and review date directly.

Our editorial processHow we use AIReport an error

NCI source

National Cancer Institute — Vemurafenib

The short answer

Zelboraf (Vemurafenib) is a targeted therapy called a kinase inhibitor. It blocks a changed BRAF protein (BRAF V600) that drives some melanomas, slowing the cancer's growth. It is used to help treat melanoma with a BRAF V600 gene change and a rare blood disorder, and is usually given as pills taken by mouth each day. Like all cancer medicines it can cause side effects; this page explains the common ones and the warning signs to report. It is educational only and not a substitute for your care team's advice.

  • Zelboraf is the brand name; its generic name is vemurafenib.

  • It is a targeted therapy called a kinase inhibitor — it blocks a changed BRAF protein (BRAF V600) that drives some melanomas, slowing the cancer's growth.

  • It is used to help treat melanoma with a BRAF V600 gene change and a rare blood disorder.

  • It is usually given as pills taken by mouth each day.

Choose how you want to understand this

The full explanation.

What it is

Zelboraf (Vemurafenib) is a cancer medicine. It is a type of targeted therapy called a BRAF inhibitor. In plain terms, it blocks a changed BRAF protein (BRAF V600) that drives some melanomas, slowing the cancer's growth. You may see it called by its brand name, Zelboraf, or by its generic name, vemurafenib. This page is a general explainer based on the National Cancer Institute's drug information; it does not replace the specific instructions your own care team gives you.

What cancers it treats

According to the National Cancer Institute, vemurafenib is approved to help treat melanoma with a BRAF V600 gene change and a rare blood disorder. Whether it is the right choice for a particular person depends on the cancer type, its stage, test results such as biomarkers, and other treatments already tried. Your oncology team can explain why it was chosen for your situation.

How it's given

As pills taken by mouth each day. It is taken as pills or capsules by mouth, often once or twice a day at home. Take it exactly as prescribed and ask your team before stopping or changing it. How much, how often, and for how long vary from person to person, so follow the exact schedule your care team gives you. If you miss an appointment or a dose, ask your team what to do rather than changing anything yourself.

Common side effects

Not everyone gets the same side effects, and some people have only mild ones. With vemurafenib, commonly reported effects include joint aches, rash, sensitivity to sunlight, tiredness, and hair loss. Many of these can be eased with supportive care. Tell your care team if you notice anything new, if a side effect is getting worse, or if it is making everyday life hard — they can often help, and knowing early usually makes problems easier to manage. Side effects do not tell you whether the medicine is working.

Serious warning signs

Some problems need prompt attention. Contact your care team right away (or use the emergency number they give you) if you notice a fever or other signs of infection, severe or watery diarrhea, new shortness of breath or swelling, and unusual bruising or bleeding. This is not a complete list, and it cannot tell you whether your own situation is an emergency — that is exactly why your team gives you personal instructions and a number to call. When in doubt, it is always reasonable to check in with them.

The bottom line

Zelboraf (Vemurafenib) is one of many tools used in cancer care. Understanding what it is, how it is given, and what to watch for can make treatment feel less overwhelming and help you speak up early about side effects. Keep a simple list of anything you notice, bring your questions to appointments, and remember that your care team — not a website — is the right source for decisions about your treatment.

Words to know

Tap any term to see what it means.

Browse the full glossary →

Common questions

What is Zelboraf?

Zelboraf (Vemurafenib) is a targeted therapy called a kinase inhibitor. It blocks a changed BRAF protein (BRAF V600) that drives some melanomas, slowing the cancer's growth. It is used to help treat melanoma with a BRAF V600 gene change and a rare blood disorder.

How is Zelboraf given?

It is usually given as pills taken by mouth each day. It is taken as pills or capsules by mouth, often once or twice a day at home. Take it exactly as prescribed and ask your team before stopping or changing it. The exact schedule is set by your care team.

What are the common side effects of Zelboraf?

Commonly reported side effects include joint aches, rash, sensitivity to sunlight, tiredness, and hair loss. Not everyone gets them, and many can be managed. Tell your care team about anything new or worsening.

Does Zelboraf cure cancer?

That depends on the person, the cancer type, and its stage. For some people a medicine like this can control cancer for a long time or be part of a curative plan; for others the goal is to slow the cancer or ease symptoms. Your care team can explain the goal in your situation.

Questions to ask your doctor

Being prepared helps you get the most out of your appointments. Save or print these questions.

Open my question list

Tap a question to save it to your list (kept on this device).

Quick quiz

Test your knowledge

0 of 3 answered

  1. Q1.What kind of medicine is Zelboraf?
  2. Q2.Which of these is Zelboraf used to help treat?
  3. Q3.If you notice a new or worsening side effect while on Zelboraf, what is the best first step?

This quiz checks understanding of educational content only. It is not medical advice. Open this quiz on its own page.

How this page was created

Cancer Explained uses AI to organize and translate information from the authoritative sources cited on each page. Automated checks review claims, citations, clarity, duplication, and potential safety concerns before publication. Our content is not currently reviewed by physicians unless a specific qualified reviewer is named on the page. Cancer Explained provides general education and should not replace advice from your healthcare team.

Editorial status: Editorial review complete This page completed Cancer Explained's editorial checks (sources, safety, plain language, duplication). It has not been reviewed by a physician or other healthcare professional.

Human medical review: not completed. At this time, most Cancer Explained content has not been reviewed by a physician or other healthcare professional. Pages with documented human medical review identify the reviewer, credentials, and review date directly.

Read more about our editorial process, our use of AI, and our corrections policy.

Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.

After using this page, do you understand what to do next?

Anonymous — we only record the answer, never who gave it.

Related learning map

How this explanation connects to 11 other things you can explore — related topics, terms, questions, practice, and its NCI source.

Zelboraf (Vemurafenib): What It Is and What to Expect